ENDOMETRIAL CARCINOSARCOMA

Clinical trials for ENDOMETRIAL CARCINOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CARCINOSARCOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for devastating Women's cancers: experimental combo therapy enters major trial

Disease control Recruiting now

This international study is testing whether combining two newer drugs (dostarlimab and niraparib) works better than using niraparib alone or standard chemotherapy for women with rare, aggressive uterine or ovarian carcinosarcoma that has returned after initial treatment. The tria…

Matched conditions: ENDOMETRIAL CARCINOSARCOMA

Phase: PHASE2, PHASE3 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ENDOMETRIAL CARCINOSARCOMA

Get alerted when new ENDOMETRIAL CARCINOSARCOMA trials appear

New hope for devastating Women's cancers: experimental combo therapy enters major trial